Therapeutics News
-
Therapeutics | News | 0 Comment | 26 Oct, 2024
The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...Read more
-
HELP Therapeutics Secures FDA Approval for Phase I Study of HiCM-188 in Heart Failure Treatment
Therapeutics | News | 0 Comment | 22 Oct, 2024
HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...Read more
-
Therapeutics | News | 0 Comment | 18 Oct, 2024
Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...Read more
-
Singapore discovers novel gene therapy offering hope for epilepsy patients
Therapeutics | News | 0 Comment | 15 Oct, 2024
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) are working on a t...Read more
-
Therapeutics | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 14 Oct, 2024
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...Read more
-
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding
Therapeutics | News | 0 Comment | 13 Oct, 2024
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...Read more
-
National University of Singapore and Imperial College London establish major research partnership
Therapeutics | News | 0 Comment | 13 Oct, 2024
National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen resear...Read more
-
Therapeutics | News | 0 Comment | 11 Oct, 2024
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...Read more
-
$18 M investment for world-first Australian research project for heart attack protection
Therapeutics | News | 0 Comment | 07 Oct, 2024
The government is investing almost $18 million in a world-first Australian research project that will trial a drug disco...Read more
-
Singapore strategises advance modalities for cancer- and age-related muscle degeneration
Therapeutics | News | 0 Comment | 26 Sep, 2024
The global population is aging rapidly, and sarcopenia, a condition that severely diminishes quality of life in older ad...Read more
-
Bio-Sourcing secures EIC Accelerator funding to enhance biomanufacturing
Therapeutics | News | 0 Comment | 24 Sep, 2024
Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces the award of €2.5M in grants and €10M in ...Read more
-
Therapeutics | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 01 Sep, 2024
Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...Read more
-
Australia designs world first wearable device to record impact of artificial light for sound sleep
Therapeutics | News | 0 Comment | 25 Aug, 2024
In a world first, a new wearable device developed by Australia's Monash University researchers will help to record the i...Read more
-
Singapore approves GSK's Jemperli plus chemotherapy as first frontline immuno-oncology treatment
Therapeutics | News | 0 Comment | 08 Aug, 2024
GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperl...Read more
-
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute's MyoAAV Plasmids
Therapeutics | News | 0 Comment | 07 Aug, 2024
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...Read more
-
Abu Dhabi announces first gene transfer therapy for duchenne muscular dystrophy
Therapeutics | News | 0 Comment | 06 Aug, 2024
Department of Health – Abu Dhabi (DoH) has provided revolutionary gene transfer therapy for Duchenne muscular dyst...Read more
-
Boston Oncology to advance localised cell and gene therapies in Saudi Arabia
Therapeutics | News | 0 Comment | 02 Aug, 2024
Under an important initiative aimed at transforming healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King ...Read more
-
Singapore MOH includes Roche’s spinal muscular atrophy (SMA) drug in MAF framework
Therapeutics | News | 0 Comment | 01 Aug, 2024
EVRYSDI® (risdiplam) has been added to the Singapore Ministry of Health’s (MOH) list of medicines covered...Read more
